1 Acura Pharmaceuticals Inc Receivables Turnover Ratio (ACUR), from the fourth quarter 2021 to the fourth quarter 2020 current and historic results, rankings and more - CSIMarket

Company Name, Ticker, Customers, else..

Growth Rates

Profitability

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

• Sales per Employee

• Income per Employee

• Inventory Turnover

• Asset Turnover

• Receivables Turnover

Dividend Comparisons

Acura Pharmaceuticals inc (NASDAQ: ACUR)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Acura Pharmaceuticals Inc Accounts Receivables Turnover Ratio from the fourth quarter 2021 to the fourth quarter 2020

Quarterly Results, Trends, Rankings, Statistics

According to Acura Pharmaceuticals Inc Balance Sheet, in the fourth quarter 2021, company has not reported any Accounts receivable.
See Acura Pharmaceuticals Inc Balance Sheet

If we take a look into Healthcare sector 64 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2021 from 964 to 972.

What is Receivable Turnover Ratio?
What is Acura Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ACUR Receivables Turnover Ratio	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	-94.99 %	-34.15 %	-54.63 %	-40.97 %	-41.15 %
Receivable Turnover Ratio (TTM)	-	-	-	-	-
ACUR's Total Ranking	# 972	# 964	# 585	# 638	# 72
Accounts Receivable average collection period days	-	-	-	-	-
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	-86.67 %	-55.95 %	-4.81 %	-10.31 %	75.12 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 19
Healthcare Sector	# 65
Overall Market	# 972

Receivable Turnover Ratio Statistics
High	Average	Low
2.08	0.68	0.01
(Jun 30 2020)		(Sep 30 2014)

ACUR Company Profile • Back to ACUR Efficiency Comparisons • Compare ACUR Receivables Turnover Ratio to its Competitors

Financial Statements
Acura Pharmaceuticals Inc's Accounts Receivable	$ 0 Millions	Visit ACUR's Balance sheet
Acura Pharmaceuticals Inc's Sales TTM	$ 2 Millions	Visit ACUR's Income Statement
Sources of ACUR's Revenues		Visit ACUR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ACUR's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ACUR's Growth Rates	ACUR's Roa	ACUR's Inventory Turnover Ratio	ACUR's Dividend Comparisons
ACUR's Profitability Ratios	ACUR's Roi	ACUR's Asset Turnover Ratio	ACUR's Dividend Growth
ACUR's Valuation Ratios	ACUR's Roe	ACUR's Financial Strength Ratios	ACUR's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2021, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Dec 31 2021

Receivable at quarter ending Dec 31 2021

Date modified: 2026-08-29T07:17:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.